Abstract
Microfluidics has advanced the area of diagnostics during the past ten years by offering fresh approaches that weren’t achievable with traditional detection and treatment techniques. High-throughput operations can be carefully controlled by using microfluidics and are very cost-effective too. It has been accepted to be a quick and effective method for controlled medication delivery, biological sample preparation, and analysis. This new technology has made it possible to create a wide range of micro and nanocarriers for poorly soluble medications, which has many advantages over traditional drug delivery techniques. Furthermore, a targeted medication delivery system utilizing microfluidic technology can be developed to enhance the drug's local bioavailability. Over the years, extensive R&D in microfluidic technology has led to the creation of various advanced applications in both laboratory and consumer biotechnology. Miniaturized genetic and proteasome analyzers, cell culture and control platforms, biosensors, disease detection, optical imaging devices, diagnostic advanced drugs, drug delivery schemes, and innovative products are some of the advanced applications of the microfluidics system. Also, these are highly adaptable microfluidic tools for disease detection and organ modeling, as well as transduction devices used in biomedical applications to detect biological and chemical changes. Beyond the specialized difficulties in studying cell–cell interactions, microfluidics has several difficulties in biomedical applications, especially for diagnostic devices where minute interactions can lead to imprecise evaluations. Assay function can be significantly changed by the way plastics, adhesives, and other materials interact. Therefore, the foundation of microfluidic technology needs to be grounded in real-world uses that can be produced on a big scale and at a reasonable cost. Further, it is a very interdisciplinary field that requires the collaboration of professionals in fluidics, assay science, materials science, and instrumentation to provide devices with the proper and needed functionality. In this article, we have discussed the advanced disease diagnosis and their therapeutic management which will help to understand the current scenario in the field of microfluidics diagnosis and will fill knowledge about the ‘gap’ in the system.
Similar content being viewed by others
Data Availability
No data was used for the research described in the article.
References
Singh A, Agarwal R, Diaz-Ruiz CA, Willett NJ, Wang P, Lee LA, Wang Q, Guldberg RE, García AJ (2014) Nanoengineered particles for enhanced intra-articular retention and delivery of proteins. Adv Healthc Mater. https://doi.org/10.1002/adhm.201400051
Duncanson WJ, Lin T, Abate AR, Seiffert S, Shah RK, Weitz DA (2012) Microfluidic synthesis of advanced microparticles for encapsulation and controlled release. Lab Chip 12:2135–2145
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261–1268
Avesar J, Arye TB, Levenberg S (2014) Frontier microfluidic techniques for short and longterm single cell analysis. Lab Chip 14:2161–2167
Wu J, Kong T, Yeung KWK, Shum HC, Cheung KMC, Wang L, To MKT (2013) Fabrication and characterization of monodisperse PLGA–alginate core–shell microspheres with monodisperse size and homogeneous shells for controlled drug release. Acta Biomater 9:7410–7419
Kochhar JS, Goh WJ, Chan SY, Kang L (2013) A simple method of microneedle array fabrication for transdermal drug delivery. Drug Dev Ind Pharm 39:299–309
Kochhar JS, Anbalagan P, Shelar SB, Neo JK, Iliescu C, Kang L (2014) Direct microneedle array fabrication off a photomask to deliver collagen through skin. Pharm Res 31:1–11
Jivani RR, Lakhtaria GJ, Patadiya DD, Patel LD, Jivani NP, Jhala BP (2013) Biomedical microelectromechanical systems (BioMEMS): revolution in drug delivery and analytical techniques. Saudi Pharm J 24:1–20
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H (2020) Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29:100587
Katz JN, Arant KR, Loeser RF (2021) Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA 325:568–578
Zhao X, Liu S, Yildirimer L, Zhao H, Ding R, Wang H et al (2016) Injectable stem cell-laden photocrosslinkable microspheres fabricated using microfluidics for rapid generation of osteogenic tissue constructs. Adv Funct Mater 26:2809–2819
Au M, Liu Z, Rong L, Zheng Y, Wen C (2020) Endothelin-1 induces chondrocyte senescence and cartilage damage via endothelin receptor type b in a post-traumatic osteoarthritis mouse model. Osteoarthr Cartil 28:1559–1571
Chen X, Zhang YS, Zhang XP, Liu CS (2021) Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine. Bioact Mater 6:1012–1027
Vunjak-Novakovic G, Ronaldson-Bouchard K, Radisic M (2021) Organs-on-a-chip models for biological research. Cell 184:4597–4611
Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE (2010) Reconstituting organ-level lung functions on a chip. Science 328:1662–1668
Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B et al (2013) Biowire: a platform for maturation of human pluripotent stem cell– derived cardiomyocytes. Nat Methods 10:781–787
Aleman J, Kilic T, Mille LS, Shin SR, Zhang YS (2021) Microfluidic integration of regeneratable electrochemical affinity-based biosensors for continual monitoring of organ-on-a-chip devices. Nat Protoc 16:2564–2593
Silva MO, Gregory JL, Ansari N, Stok KS (2020) Molecular signaling interactions and transport at the osteochondral interface: a review. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2020.00750
Shi X, Zhou J, Zhao Y, Li L, Wu H (2013) Gradient-regulated hydrogel for interface tissue engineering: steering simultaneous osteo/chondrogenesis of stem cells on a chip. Adv Healthc Mater 2:846–853
Prokai-Tatrai K, Prokai L (2003) Modifying peptide properties by prodrug design for enhanced transport into the CNS. Prog Drug Res 61:155–188. https://doi.org/10.1007/978-3-0348-8049-7_6
Huot P, Fox SH (2011) The serotonergic system in Parkinson’s disease. Prog Neurobiol 95:163–212. https://doi.org/10.1016/j.pneurobio.08.004
Perry M, Li Q, Kennedy RT (2009) Review of recent advances in analytical techniques for the determination of neurotransmitters. Anal Chim Acta 653:1–22
Trouillon R, Svensson MI, Berglund EC, Cans AS, Ewing AG (2012) Highlights of selected recent electrochemical measurements in living systems. Electrochim Acta 84:84–95. https://doi.org/10.1016/j.electacta.2012.04.164
Wang J, Ren L, Li L, Liu W, Zhou J, Yu W, Tong D, Chen S (2009) Microfluidics: a new cosset for neurobiology. Lab Chip 9:644–52. https://doi.org/10.1039/b813495b
Nandi P, Lunte SM (2009) Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. Anal Chim Acta 651:1–14. https://doi.org/10.1016/j.aca.2009.07.064
Hanson JN, Motala MJ, Heien ML, Gillette M, Sweedler J, Nuzzo RG (2009) Textural guidance cues for controlling process outgrowth of mammalian neurons. Lab Chip 9:122–31. https://doi.org/10.1039/b803595d
Clark P, Britland S, Connolly P (1993) Growth cone guidance and neuron morphology on micropatterned laminin surfaces. J Cell Sci 105:203–212. https://doi.org/10.1242/jcs.105.1.203
Rogers JA, Nuzzo RG (2005) Recent progress in soft lithography. Mater Today 8:50–56
Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO (2020) Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano 14:7760–7782. https://doi.org/10.1021/acsnano.0c04006
Liu Y, Workalemahu B, Jiang X (2017) The effects of physicochemical properties of nanomaterials on their cellular uptake in vitro and in vivo. Small 13:1701815. https://doi.org/10.1002/smll.201701815
Mishra DK, Shandilya R, Mishra PK (2018) Lipid based nanocarriers: a translational perspective. Nanomed Nanotechnol, Biol Med 14:2023–2050. https://doi.org/10.1016/j.nano.2018.05.021
Zhao Z, Cui H, Song W, Ru X, Zhou W, Yu X (2020) A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2. bioRxiv. https://doi.org/10.1101/2020.02.22.961268
Qiu G, Gai Z, Tao Y, Schmitt J, Kullak-Ublick GA, Wang J (2020) Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection. ACS nano 14:5268–5277
Shapiro RS (2021) COVID-19 vaccines and nanomedicine. Int J Dermatol. https://doi.org/10.1111/ijd.15673
Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K et al (2021) Nanomedicine for the SARS-CoV-2: state-of-the-art and future prospects. Int J Nanomedicine 16:539. https://doi.org/10.2147/ijn.s283686
Li F, Qi J, Ren Z, Hu X, Chen Y, Li B, Fu X (2023) Tetrahedral DNA framework assisted rotational paper-based analytical device for differential detection of SARS-CoV-2 and influenza A H1N1 virus. Microchem J 185:108304
Alhadrami HA (2018) Biosensors classifications, medical applications, and future prospective. Biotechnol Appl Biochem 65:497–508
Alsabbagh K, Hornung T, Voigt A, Sadir S, Rajabi T, Lange K (2021) Microfluidic impedance biosensor chips using sensing layers based on DNA-based self-assembled monolayers for label-free detection of proteins. Biosensors 11:80
Xing Y, Zhao L, Cheng Z, Lv C, Yu F, Yu F (2021) Microfluidics-based sensing of biospecies. ACS Appl Bio Mater 4:2160–2191
Welch NL, Zhu M, Hua C, Weller J, Mirhashemi ME, Nguyen TG et al (2022) Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants. Nat Med 28(5):1083–1094. https://doi.org/10.1038/s41591-022-01734-1. (Erratum in: Nat Med. 2024; 30(1):307)
Sundar S, Khetrapal-Singh P, Frampton J, Trimble E, Rajaraman P, Mehrotra R, Hariprasad R, Maitra A, Gill P, Suri V, Srinivasan R, Singh G, Thakur JS, Dhillon P, Cazier JB (2018) Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research. Lancet Oncol 19:e102–e112. https://doi.org/10.1016/S1470-2045(17)30726-X.Erratum.In:LancetOncol.2018Jun;19(6):e283
Robin P, Barnabei L, Marocco S, Pagnoncelli J, Nicolis D, Tarantelli C, Tavilla AC, Robortella R, Cascione L, Mayoraz L, Journot CM (2023) A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus. Biosens Bioelectron: X 13:100302
Fumet J-D, Truntzer C, Yarchoan M, Ghiringhelli F (2020) Tumour mutational burden as a biomarker for immunotherapy: current data and emerging concepts. Eur J Cancer 131:40–50
Suh RS, Zhu X, Phadke N et al (2006) IVF within microfluidic channels requires lower total numbers and lower concentrations of sperm. Hum Reprod 21:477–483
Swain J, Lai D, Takayama S et al (2013) Thinking big by thinking small: application of microfluidic technology to improve ART. Lab Chip 13:1213–1224
Han C, Zhang Q, Ma R et al (2010) Integration of single oocyte trapping, in vitro fertilization and embryo culture in a microwell-structured microfluidic device. Lab Chip 10:2848–2854
Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3:16–20
Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–782
Amiji MM, Vyas TK, Shah LK (2006) Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge. Discov Med 6:157–162
Pornillos O, Ganser-Pornillos BK, Kelly BN et al (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137:1282–1292
Parsa H, Wang BZ, Vunjak-Novakovic GA (2017) microfluidic platform for the high-throughput study of pathological cardiac hypertrophy. LChip 17:3264–3271
Shang L, Cheng Y, Zhao Y (2017) Emerging droplet microfluidics. Chem Rev 117:7964–8040
Demello AJ (2006) Control and detection of chemical reactions in microfluidic systems. Nature 442:394–402
Wang S et al (2020) Inner surface design of functional microchannels for microscale flow control. Small 16:1905318
Huang G et al (2017) Functional and biomimetic materials for engineering of the three-dimensional cell microenvironment. Chem Rev 117:12764–12850
Hong YJ, Jeong H, Cho KW, Lu N, Kim DH (2019) Wearable and implantable devices for cardiovascular healthcare: from monitoring to therapy based on flexible and stretchable electronics. Adv Funct Mater 29:1808247
Klostranec JM, Xiang Q, Farcas GA, Lee JA, Rhee A, Lafferty EI, Perrault SD, Kain KC, Chan WC (2007) Convergence of quantum dot barcodes with microfluidics and signal processing for multiplexed high-throughput infectious disease diagnostics. Nano lett 7:2812–2818
Chen L, Fatima S, Peng J, Leng X (2009) SELDI protein chip technology for the detection of serum biomarkers for liver disease. Protein Pept Lett 16:467–472
Foudeh AM, Didar TF, Veres T, Tabrizian M (2012) Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics. Lab Chip 12:3249–3266
Kodani M, Mixson-Hayden T, Drobeniuc J, Kamili S (2014) Rapid and sensitive approach to simultaneous detection of genomes of hepatitis A, B, C, D and E viruses. J Clin Virol 61:260–264
Chang HC, Chao YT, Yen JY, Yu YL, Lee CN, Ho BC, Liu KC, Fang J, Lin CW, Lee JH (2015) A turbidity test based centrifugal microfluidics diagnostic system for simultaneous detection of HBV, HCV, and CMV. Adv Mater Sci Eng 2015: 1–8
Duan L, Wang Y, Li S-S, Wan Z, Zhai J (2005) Rapid and simultaneous detection of human hepatitis B virus and hepatitis C virus antibodies based on a protein chip assay using nano-gold immunological amplification and silver staining method. BMC Infect Dis 5:53
Alzheimer’s Association (2020) Available online: https://www.alz.org/alzheimers-dementia/what-isalzheimers (Accessed on 18 June 2020)
Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J (2006) MCI Working Group of the European Consortium on Alzheimer’s Disease (EADC). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI working group of the European consortium on Alzheimer’s disease. J Neurol Neurosurg Psychiatry 77:714–718
Yeo LY, Chang HC, Chan PPY, Friend JR (2011) Microfluidic devices for bioapplications. Small 7:12–48
Lee S-A, Kang E, Ju J, Kim D-S, Lee S-H (2013) Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte–hepatic stellate cell interactions and flow effects. Lab Chip 13:3529–3537
Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, Chen Z (2017) Modeling physiological events in 2D vs. 3D cell culture. Physiology 32:266–277
Yi YY, Park JS, Lim J, Lee CJ, Lee SH (2015) Central nervous system and its disease models on a chip. Trends Biotechnol 33:762–776
Lista S, O’Bryant SE, Blennow K, Dubois B, Hugon J, Zetterberg H, Hampel H (2015) Biomarkers in sporadic and familial Alzheimer’s disease. J Alzheimers Dis 47:291–317
Irizarry MC (2004) Biomarkers of Alzheimer disease in plasma. NeuroRx 1:226–234
Lista S, O’Bryant SE, Blennow K, Dubois B, Hugon J, Zetterberg H, Hampel H, Shen Y (2015) Biomarkers in sporadic and familial Alzheimer’s disease. J Alzheimers Dis 47:291–317
Hampel H, O’Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14:639–652
Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913–4917
Fillit HM, Refolo LM (2002) Tau and Alzheimer’s disease. J Mol Neurosci 19:249–250
Overmyeapiola T, Lehtovirta M, Helisalmi S, Ramberg J, Alafuzoff I, Riekkinen PS, Soininen H (1997) The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer’s disease. NeuroReport 8:3961–3963
Vanmechelen E, Vanderstichele H, Davidsson P, Kerschaver EV, Perre BVD, Sjögren M, Andreasen N, Blennow K (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci. Lett 285:49–52
Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233:183–198
Bacioglu M, Maia L, Preische O, Schelle J, Jucker M (2016) Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron 91:494–496
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, Lafougere C, Laske C et al (2019) Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat Med 25:277–283
Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, Cheo D, D’Andrade P, DeMayo M, Dennis L et al (2014) Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods 11:809–815
Boeri M, Verri C, Conte D, Roz L, Sozzi G (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 108:3713–3718
Hébert SS, Wang WX, Zhu Q, Nelson PT (2013) A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer’s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis 35:335–348
Kenny AMH, Calero M, Rabano A, Madden SF, Adamson K, Forster R, Spain E, Prehn JH, Henshall DC, Medina M et al (2019) Elevated plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment. Biomolecules 9:734
Bianco F, Tonna N, Lovchik RD, Mastrangelo R, Morini R, Ruiz A, Delamarche E, Matteoli M (2012) Overflow microfluidic networks: application to the biochemical analysis of brain cell interactions in complex neuroinflammatory scenarios. Anal Chem 84:9833–9840
Urich E, Patsch C, Aigner S, Graf M, Iacone R, Freskgård P-O (2013) Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep 3:1500
Cho CF, Wolfe JM, Fadzen CM, Calligaris D, Hornburg K, Chiocca EA, Agar NYR, Pentelute BL, Lawler SE (2017) Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun 8:15623
Song HL, Shim S, Kim DH, Won SH, Joo S, Kim S, Jeon NL, Yoon SY (2014) β-Amyloid is transmitted via neuronal connections along axonal membranes. Ann Neurol 75:88–97
Lee JS, Ryu J, Park CB (2009) High-throughput analysis of Alzheimer’s beta-amyloid aggregation using a microfluidic self-assembly of monomers. Anal Chem 81:2751–2759
Lee JS, Park CB (2010) Microfluidic dissociation and clearance of Alzheimer’s beta-amyloid aggregates. Biomaterials 31:6789
Li W, Xu Z, Xu B, Chan CY, Lin X, Wang Y, Chen G, Wang Z, Yuan Q, Zhu G (2017) Investigation of the subcellular neurotoxicity of amyloid-β using a device integrating microfluidic perfusion and chemotactic guidance. Adv Healthc Mat 6:160895
Cho H, Hashimoto T, Wong E, Hori Y, Wood LB, Zhao L, Haigis KM, Hyman BT, Irimia D (2013) Microfluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-β on microglial accumulation. Sci Rep 3:1823
Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, Sanders DW, Cook C, Fu H, Boonen RACM (2016) Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci 19:1085–1092
Claeysen S, BockaertJl GP (2015) Serotonin: a new hope in Alzheimer’s disease? ACS Chem Neurosci 6:940–943
LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-β in Alzheimer’s disease. Nat Rev Neurosci 8:499–509
Béduer A, Joris P, Mosser S, Fraering PC, Renaud P (2015) Detection of Alzheimer’s disease amyloid-beta plaque deposition by deep brain impedance profiling. J Neural Eng 12:024001
Zhang X, Tian Y, Li Z, Tian X, Sun H, Liu H, Moore A, Ran C (2013) Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer’s disease. J Am Chem Soc 135:16397–409
Oh J, Yoo G, Chang YW, Kim HJ, Jose J, Kim E, Pyun JC, Yoo KH (2013) A carbon nanotube metal semiconductor field effect transistor-based biosensor for detection of amyloid-beta in human serum. Biosens Bioelectron 50:345–350
Georganopoulou DG, Chang L, Jwa-Min Nam C, Thaxton S, Mufson EJ, Klein WL, Mirkin CA (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease. Proc Nat Acad Sci 102:2273–2276. https://doi.org/10.1073/pnas.0409336102
Kaushik A, Yndart A, Jayant RD, Sagar V, Atluri V, Bhansali S, Nair M (2015) Electrochemical sensing method for point-of-care cortisol detection in human immunodeficiency virus-infected patients. Int J Nanomed 10:677
Vestergaard Md, Kerman K, Saito M, Nagatani N, Takamura Y, Tamiya EJ (2005) A rapid label-free electrochemical detection and kinetic study of Alzheimer’s amyloid beta aggregation. Am Chem Soc 127:11892–11893
Oh J, Yoo G, Chang YW, Kim HJ, Jose J, Kim E, Pyun JC, Yoo KH (2013) A carbon nanotube metal semiconductor field effect transistor-based biosensor for detection of amyloid-beta in human serum. Biosens Bioelectron 50:345–350
Li J, Wu C, Chu PK, Gelinsky M (2020) 3d printing of hydrogels: Rational design strategies and emerging biomedical applications. Mater Sci Eng R Rep 140:100543
Lewis JA (2006) Direct ink writing of 3d functional materials. Adv Func Mater 16:2193–2204
Derby B (2010) Inkjet printing of functional and structural materials: fluid property requirements, feature stability, and resolution. Annu Rev Mater Res 40:395–414
Tumbleston JR, Shirvanyants D, Ermoshkin N, Janusziewicz R, Johnson AR, Kelly D, Chen K, Pinschmidt R, Rolland JP, Ermoshkin A et al (2015) Continuous liquid interface production of 3d objects. Science 347:1349–1352
Jayamohan H, Sant HJ, Gale BK (2013) Applications of microfluidics for molecular diagnostics. Methods Mol Biol 949:305–334. https://doi.org/10.1007/978-1-62703-134-9_20.PMID:23329451
Acknowledgements
Authors are grateful to Dr. Shoor Vir Singh, Professor and Head, Department of Biotechnology at GLA University, Mathura for help and support during the present study.
Funding
This review did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Saurabh G, AB contributed to the conceptualization, literature search, data collection, study design; Swadha G, AR contributed to critical review and preparation of the final version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest regarding the publication of this manuscript.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pandey, S., Gupta, S., Bharadwaj, A. et al. Microfluidic Systems: Recent Advances in Chronic Disease Diagnosis and Their Therapeutic Management. Indian J Microbiol (2024). https://doi.org/10.1007/s12088-024-01296-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12088-024-01296-5